Trial Profile
A retrospective trial to evaluate the role of 99mTc-sestamibi (MIBI) brain single-photon emission tomography (SPET) in patients with glioblastoma multiforme after chemotherapy with Carmustine-polifeprosan-20-wafer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Carmustine polifeprosan 20 wafer (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 09 Dec 2015 New trial record